...
机译:高精度的多巴胺D3R拮抗剂,R-VK4-40衰减羟考酮奖励和啮齿动物中的镇痛
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
Johns Hopkins Univ Sch Med Dept Neurol Johns Hopkins Drug Discovery 855 N Wolfe St Baltimore;
Johns Hopkins Univ Sch Med Dept Neurol Johns Hopkins Drug Discovery 855 N Wolfe St Baltimore;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
NIDA Mol Targets &
Medicat Discovery Branch Intramural Res Program Baltimore MD 21224 USA;
Oxycodone; R-VK4-40; D-3 receptor antagonist; Self-administration; Brain-stimulation reward; Opioid analgesia;
机译:高精度的多巴胺D3R拮抗剂,R-VK4-40衰减羟考酮奖励和啮齿动物中的镇痛
机译:基于依替普利特和D3R晶体结构的高选择性多巴胺D-3受体(D3R)拮抗剂和部分激动剂:阿片类药物依赖性治疗的新线索
机译:新开发的多巴胺D-3受体拮抗剂,R-VK4-40和R-VK4-116,不要在大鼠中加强可卡因或羟考酮的心血管作用
机译:L- StepHolidine,天然存在的多巴胺D1受体激动剂和D2受体拮抗剂,衰减甲基苯丙胺自我管理
机译:基于艾替普利特和D3R晶体结构的高选择性多巴胺D3受体(D3R)拮抗剂和部分激动剂:阿片类药物依赖治疗的新线索
机译:新开发的多巴胺D3受体拮抗剂,R-VK4-40和R-VK4-116,不要在大鼠中加强可卡因或羟考酮的心血管作用